Provention Bio, Inc. (PRVB) Social Stream
PROVENTION BIO INC (PRVB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRVB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-09 | 5 | $25 | $16 | $19.875 | $24.98 | -20.44% |
| 2022-05-20 | 5 | $25 | $12 | $18.3 | $24.98 | -26.74% |
| 2022-08-04 | 5 | $22.5 | $12 | $16.9 | $24.98 | -32.35% |
| 2022-08-06 | 5 | $21 | $10 | $16.2 | $24.98 | -35.15% |
| 2022-08-24 | 5 | $21 | $10 | $15.8 | $24.98 | -36.75% |
| 2022-10-06 | 6 | $21 | $10 | $14.833 | $24.98 | -40.62% |
| 2022-10-07 | 6 | $21 | $10 | $15.666 | $24.98 | -37.29% |
| 2022-11-04 | 6 | $24 | $10 | $16.166 | $24.98 | -35.28% |
| 2022-11-06 | 6 | $24 | $10 | $16.666 | $24.98 | -33.28% |
| 2022-11-08 | 6 | $24 | $12 | $17 | $24.98 | -31.95% |
| 2022-11-17 | 6 | $24 | $12 | $17.666 | $24.98 | -29.28% |
| 2022-11-21 | 6 | $24 | $16 | $18.333 | $24.98 | -26.61% |
| 2023-02-15 | 6 | $30 | $16 | $20.166 | $24.98 | -19.27% |
| 2023-03-13 | 5 | $25 | $16 | $19.6 | $24.98 | -21.54% |
| 2023-03-15 | 6 | $25 | $19 | $24 | $24.98 | -3.92% |
The Trend in the Analyst Price Target
PRVB's average price target has moved up $7.83 over the prior 131 days.
Over the past 45 weeks, PRVB's average upside potential has been 170.79%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-06 | 6 | 21 | 10 | 14.833 | 6.22 | 138.47% |
| 2022-11-17 | 6 | 24 | 12 | 17.666 | 8.24 | 114.39% |
| 2023-02-15 | 6 | 30 | 16 | 20.500 | 9.65 | 112.44% |
| 2023-03-13 | 5 | 25 | 16 | 19.600 | 24.10 | -18.67% |
| 2023-03-15 | 6 | 25 | 16 | 22.500 | 23.91 | -5.9% |
PRVB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 2 | 0 | 4 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
PRVB's average broker recommendation rating worsened by 0.8 over the prior 120 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRVB as an investment opportunity.
- PRVB has a higher upside potential (average analyst target price relative to current price) than 48.07% of all US stocks.
- In the context of all US stocks, PROVENTION BIO INC's average analyst price target is greater than 459.21% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, PROVENTION BIO INC's number of analysts covering the stock is higher than 609.14% of them.
- PRVB has a lower variance in analysts' estimates than -1203.8% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PROVENTION BIO INC are ALLK, AMRX, and MOR.
View All Top Stocks by Price Target
Make investment decisions regarding PRVB using the data that counts. Try POWR Ratings for free.